Clinical Trials List
Protocol NumberDIA-PK01
Not yet recruiting
2009-04-01 - 2009-04-30
Phase I
Terminated1
-
Trial Applicant
TWI PHARMACEUTICALS, INC.
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
24 participants
